Topic · page 11 of 12

Across rheumatic diseases

Only studies that genuinely span several rheumatic diseases, such as drug safety and pharmacovigilance, infection, vaccination and comorbidity (cardiovascular, cancer, mental health) across diseases, and health services and quality of care across diseases. Never a fallback for an article that is hard to place

Briefs 401–440 of 474 placed here, newest publication first

Briefs in Across rheumatic diseases

Newest publication first

Rheumatology (Oxford)27 Mar 2023
Unpublished clinical trials of common rheumatic diseases
Cross-sectional study
Rheumatology (Oxford)24 Mar 2023
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys
Research article
Arthritis Care Res (Hoboken)23 Mar 2023
Clinical Visit Frequencies in Rheumatology: A Systematic Literature Review
Research article
Scand J Rheumatol20 Mar 2023
Construct validity of the PROMIS PF-10 in patients with inflammatory rheumatic diseases and severe limitations in physical functioning
Cross-sectional study
Rheumatology (Oxford)13 Mar 2023
10-year survival of pulmonary arterial hypertension associated with connective tissue disease: insights from a multicentre PAH registry
Cohort study
Arthritis Res Ther2 Mar 2023
Machine learning identification of thresholds to discriminate osteoarthritis and rheumatoid arthritis synovial inflammation
Diagnostic or prognostic study
RMD Open2 Mar 2023
Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease: an extension study (RESCUE 2)
Research article
Clin Exp Rheumatol2 Mar 2023
ERN ReCONNET points to consider for treating patients living with autoimmune rheumatic diseases with antiviral therapies and anti-SARS-CoV-2 antibody products
Guideline or statement
RMD Open2 Mar 2023
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
Guideline or statement
Ann Rheum Dis1 Mar 2023
2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice
Guideline or statement
Rheumatology (Oxford)25 Feb 2023
Measuring the impact of steroid therapy on health-related quality of life in patients with rheumatic diseases: international development of a glucocorticoid treatment–specific patient-reported outcome measure
Research article
Arthritis Care Res (Hoboken)13 Feb 2023
Sleep Disturbance and SARS–CoV‐2 Vaccinations in Patients With Chronic Inflammatory Disease
Cohort study
Rheumatology (Oxford)10 Feb 2023
Fourth dose of BNT162b2 vaccine for patients with autoimmune rheumatic diseases in a nationwide setting
Cohort study
Scand J Rheumatol6 Feb 2023
Disease activity-guided tapering of biologics in patients with inflammatory arthritis: a pragmatic, randomized, open-label, equivalence trial
Randomized controlled trial
Scand J Rheumatol6 Feb 2023
Health-related quality of life in gout, psoriatic arthritis, rheumatoid arthritis and ankylosing spondylitis, results from a cross-sectional survey in Western Sweden
Cross-sectional study
Semin Arthritis Rheum28 Jan 2023
Causal association of leisure sedentary behavior with arthritis: A Mendelian randomization analysis
Research article
Ann Rheum Dis26 Jan 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022
Guideline or statement
Lancet Rheumatol23 Jan 2023
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study
Cohort study
Arthritis Care Res (Hoboken)23 Jan 2023
Frequency and Clinical Utility of Antibodies to Extractable Nuclear Antigen in the Setting of a Negative Antinuclear Antibody Test
Cohort study
J Rheumatol15 Jan 2023
Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines Against COVID-19 Infection Among Patients With Systemic Autoimmune Rheumatic Diseases on Immunomodulatory Medications
Cohort study
J Rheumatol15 Jan 2023
Preferences for COVID-19 Vaccination in People With Chronic Immune-Mediated Inflammatory Diseases
Cross-sectional study
J Rheumatol15 Jan 2023
Physical Activity Habits Among Older Adults Living With Rheumatic Disease
Cross-sectional study
Lancet Rheumatol10 Jan 2023
Breakthrough SARS-CoV-2 infections and prediction of moderate-to-severe outcomes during rituximab therapy in patients with rheumatic and musculoskeletal diseases in the UK: a single-centre cohort study
Cohort study
Lupus4 Jan 2023
Possible relationship between hydroxychloroquine and electrocardiographic and echocardiographic abnormalities in patients with inflammatory rheumatic diseases––a monocentric study
Cross-sectional study
Arthritis Rheumatol4 Jan 2023
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases
Guideline or statement
Arthritis Care Res (Hoboken)4 Jan 2023
2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases
Guideline or statement
RMD Open3 Jan 2023
Non-pharmacological interventions to promote work participation in people with rheumatic and musculoskeletal diseases: a systematic review and meta-analysis from the EULAR taskforce on healthy and sustainable work participation
Meta-analysis
JAMA Netw Open3 Jan 2023
Health and Economic Outcomes Associated With Musculoskeletal Disorders Attributable to High Body Mass Index in 192 Countries and Territories in 2019
Cross-sectional study
Arthritis Care Res (Hoboken)17 Dec 2022
Hydroxychloroquine Use and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis
Case-control study
J Rheumatol15 Dec 2022
Oral Antiviral Treatment for COVID-19 in Patients With Systemic Autoimmune Rheumatic Diseases
Cohort study
J Rheumatol15 Dec 2022
High Prevalence of Foot Insufficiency Fractures in Patients With Inflammatory Rheumatic Musculoskeletal Diseases
Cohort study
J Rheumatol15 Dec 2022
B Cell Reconstitution is Associated With COVID-19 Booster Vaccine Responsiveness in Patients Previously Seronegative Treated With Rituximab
Cohort study
J Rheumatol15 Dec 2022
COVID-19 Vaccination Perceptions in Patients With Rheumatic Disease: A Cross-Sectional Online Survey
Cross-sectional study
Arthritis Care Res (Hoboken)7 Dec 2022
Equity Considerations in COVID‐19 Vaccination Studies of Individuals With Autoimmune Inflammatory Rheumatic Diseases
Meta-analysis
Clin Exp Rheumatol2 Dec 2022
Hydroxychloroquine exposure reduces the risk of cardiovasular disease events in patients with hypertension or diabetes mellitus
Cohort study
Rheumatology (Oxford)29 Nov 2022
Rituximab-treated rheumatic patients: B cells predict seroconversion after COVID-19 boost or revaccination in initial vaccine non-responders
Cohort study
Ann Rheum Dis28 Nov 2022
Impact of vaccination on postacute sequelae of SARS CoV-2 infection in patients with rheumatic diseases
Cohort study
Semin Arthritis Rheum21 Nov 2022
SARS-CoV-2 infection among patients with autoimmune rheumatic diseases; comparison between the Delta and Omicron waves in Israel
Cohort study
Arthritis Care Res (Hoboken)20 Nov 2022
Continuing Professional Development in Rheumatology for Primary Care Clinicians: A Systematic Review
Meta-analysis
Arthritis Care Res (Hoboken)18 Nov 2022
Association Between Neighborhood Deprivation and Number of Rheumatology Providers
Cross-sectional study

All 474 Briefs in ExploreShowing Briefs 401–440 of 474, newest first